Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find Clinical Trials & Studies

E2023-A001-304

I'm Interested!

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study With Open-Label Extension Phase of Lorcaserin as Adjunctive Treatment in Subjects With Dravet Syndrome

  • Sex at Birth: Any
  • Age: Child (Birth - 17), Adult (18 - 64), Older Adult (65+)
  • Accepting Healthy People: No
  • Type: Interventional / Therapeutic
  • Trial Phase: Phase III
  • Conditions Being Studied: Epilepsy

Study Purpose

The purpose of this study is to assess the safety (symptoms and medical problems you may experience –known as side effects) and efficacy (how well and for how long the study drug treated) of the study drug on subjects who have Dravet syndrome.

Who Can Participate

Age: 2 years and older

Principal Investigator
Jennifer Waldron DO
Department/Division
Neurology (Pediatrics)

Locations

UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106

  • UH IRB: STUDY20210262
  • StudyID: 2021-0530
  • ClinicalTrials.gov: NCT04572243
I'm Interested!

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-800-641-2422